Verlaan, D. J., Laurent, S. B., Rochefort, D. L., Liquori, C. L., Marchuk, D. A., Siegel, A. M., & Rouleau, G. A. (2004). CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations. Ann Neurol, 55(5), 757–758. https://doi.org/10.1002/ana.20112

Verlaan, Dominique J., Sandra B. Laurent, Daniel L. Rochefort, Christina L. Liquori, Douglas A. Marchuk, Adrian M. Siegel, and Guy A. Rouleau. “CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations.” Ann Neurol 55, no. 5 (May 2004): 757–58. https://doi.org/10.1002/ana.20112.

Verlaan DJ, Laurent SB, Rochefort DL, Liquori CL, Marchuk DA, Siegel AM, et al. CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations. Ann Neurol. 2004 May;55(5):757–8.

Verlaan, Dominique J., et al. “CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations.” Ann Neurol, vol. 55, no. 5, May 2004, pp. 757–58. Pubmed, doi:10.1002/ana.20112.

Verlaan DJ, Laurent SB, Rochefort DL, Liquori CL, Marchuk DA, Siegel AM, Rouleau GA. CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations. Ann Neurol. 2004 May;55(5):757–758.